Dasatinib and Midazolam drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Dasatinib (dasatinib) and Midazolam (midazolam). Common drug interactions include hypotension among females and abdominal pain among males.

The phase IV clinical study analyzes what interactions people have when they take Dasatinib and Midazolam. It is created by eHealthMe based on reports of 14 people who take the same drugs from the FDA, and is updated regularly.

What is Dasatinib?

Dasatinib has active ingredients of dasatinib. eHealthMe is studying from 9,407 Dasatinib users. Check the latest studies of Dasatinib.

What is Midazolam?

Midazolam has active ingredients of midazolam. eHealthMe is studying from 11,246 Midazolam users. Check the latest studies of Midazolam.

On Jul, 11, 2026

14 people who take Dasatinib and Midazolam together, and have interactions are studied.

Dasatinib and Midazolam drug interactions.

What are the common drug interactions of Dasatinib and Midazolam, by gender? *:

female:

Hypotension (abnormally low blood pressure)
Acute hepatic failure
Cytomegalovirus enterocolitis (virus infection of intestine and colon)
Shock (a life-threatening condition with symptoms like low blood pressure, weakness, shallow breathing, cold, clammy skin)
Anaemia (lack of blood)
Cytokine release syndrome (immediate complication occurring with the use of anti-t cell antibody infusions)
Dyspnoea (difficult or laboured respiration)
Hallucination, visual (seeing things that aren't there)
Hypoxia (low oxygen in tissues)
Pneumonitis (inflammation of the walls of the alveoli in the lungs)

male:

Abdominal pain
Diarrhoea
Cluster headache (one-sided head pain with tearing)
Cough
Drug intolerance (drug sensitivity)
Dyspepsia (indigestion)
Erectile dysfunction
Intervertebral disc protrusion (spinal disc protrusion)
Mitral valve stenosis (narrowing of mitral valve)
Myalgia (muscle pain)

What are the common drug interactions of Dasatinib and Midazolam, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

Acute hepatic failure
Cytomegalovirus enterocolitis (virus infection of intestine and colon)
Hypotension (abnormally low blood pressure)
Shock (a life-threatening condition with symptoms like low blood pressure, weakness, shallow breathing, cold, clammy skin)
Abdominal pain
Jaundice (a yellowish pigmentation of the skin, the conjunctival membranes)
Nausea (feeling of having an urge to vomit)
Vomiting
Respiratory disorder (respiratory disease)

20-29:

Abdominal pain
Diarrhoea
Haematocrit decreased
Haemolysis (breaking open of red blood cells and the release of haemoglobin into the surrounding fluid)
Red blood cell count decreased
Thrombocytopenia (decrease of platelets in blood)

30-39:

Abdominal pain
Diarrhoea

40-49:

n/a

50-59:

Cytokine release syndrome (immediate complication occurring with the use of anti-t cell antibody infusions)
Pyrexia (fever)
Tumour lysis syndrome (a group of metabolic complications that can occur after treatment of cancer, these complications are caused by the breakdown products of dying cancer cells)

60+:

Anaemia (lack of blood)
Cytokine release syndrome (immediate complication occurring with the use of anti-t cell antibody infusions)
Thrombocytopenia (decrease of platelets in blood)
Dyspnoea (difficult or laboured respiration)
Hallucination, visual (seeing things that aren't there)
Hypotension (abnormally low blood pressure)
Hypoxia (low oxygen in tissues)
Pneumonitis (inflammation of the walls of the alveoli in the lungs)
Pulmonary oedema (fluid accumulation in the lungs)
Pyrexia (fever)

What are the existing conditions these people have? *

Chronic Myeloid Leukaemia (long lasting type of cancer that starts in the blood-forming cells of the bone marrow and invades the blood): 7 people, 50.00%
Pneumonia: 4 people, 28.57%
Mesothelioma Malignant (cancer that occurs in the thin layer of cells lining the body's internal organs, known as the mesothelium): 3 people, 21.43%
Agitation (state of anxiety or nervous excitement): 3 people, 21.43%
Secretion Discharge: 3 people, 21.43%
Respiratory Distress (difficulty in breathing): 3 people, 21.43%
Pleural Effusion (water on the lungs): 3 people, 21.43%
Dyspnea (difficult or laboured breathing): 3 people, 21.43%
Mesothelioma (rare type of cancer that occurs in the thin layer of cells lining the body's internal organs, known as the mesothelium): 3 people, 21.43%
Ovarian Cancer (cancer of ovary): 2 people, 14.29%

* Approximation only. Some reports may have incomplete information.

Do you take Dasatinib and Midazolam?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously